The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
Open accessAbstract
Objective: To estimate the prevalence, types, and sociodemographic and biobehavioral correlates of antinuclear antibodies (ANAs) in the US. Methods: We conducted a cross‐sectional analysis of 4,754 individuals from the National Health and Nutrition Examination Survey 1999–2004. ANAs were assessed by indirect immunofluorescence. In ANA‐positive individuals, cellular staining patterns were determined, and specific autoantibody reactivities were assessed by immunoprecipitation. Results: The ANA prevalence in the US population of individuals ages 12 years and older was 13.8% (95% confidence interval [95% CI] 12.2–15.5%). ANA prevalence increased with age ( P = 0.01), and ANAs were more prevalent among females than males (17.8% versus 9.6%; P < 0.001), with the female‐to‐male ratio peaking at 40–49 years of age. ANA prevalence was modestly higher in African Americans compared with whites (age‐adjusted prevalence odds ratio [POR] 1.30, 95% CI 1.00–1.70). Remarkably, ANAs were less common in overweight and obese individuals (age‐adjusted POR 0.74) than in persons of normal weight. No significant associations of ANA with education, family income, alcohol use, smoking history, serum levels of cotinine, or C‐reactive protein were observed. In ANA‐positive individuals, nuclear patterns were seen in 84.6%, cytoplasmic patterns were seen in 21.8%, and nucleolar patterns were seen in 6.1%; the most common specific autoantibodies were anti‐Ro (3.9%) and anti‐Su (2.4%). Conclusion: These findings suggest that more than 32 million persons in the US have ANAs, and that the prevalence is higher among females, older individuals, African Americans, and those with a normal body weight. These data will serve as a useful baseline for future investigations of predictors and changes in ANA prevalence over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021933 · Cited by 2,578
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667 · cited 1×
“Thus, defining the prevalence and types of ANA, as well as characterizing factors associated with their production, may provide insight into the etiology of autoimmune diseases, which are thought to be increasing in frequency but are more difficult to characterize and study than ANA at the population level (18).”
BackgroundAntinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
Tan, E. M. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60641-0 · Cited by 1,514
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Assessment of Child and Adolescent Overweight and Obesity
Krebs, N. F., Himes, J. H., Jacobson, D., Nicklas, T. A., Guilday, P., & Styne, D. (2007) · Pediatrics · doi:10.1542/peds.2007-2329d · Cited by 981
Pirkle, J. L. (1996) · JAMA · doi:10.1001/jama.275.16.1233 · Cited by 704
Range of antinuclear antibodies in “healthy” individuals
Tan, E. M., Feltkamp, T. E. W., Smolen, J. S., Butcher, B., Dawkins, R., Fritzler, M. J., Gordon, T., Hardin, J. A., Kalden, J. R., Lahita, R. G., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400909 · Cited by 702
Cited by
Agmon-Levin, N., Damoiseaux, J., Kallenberg, C., Sack, U., Witte, T., Herold, M., Bossuyt, X., Musset, L., Cervera, R., Plaza-Lopez, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203863 · Cited by 615
Self-citationSatoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Self-citationChang, K., Frankovich, J., Cooperstock, M., Cunningham, M. W., Latimer, M. E., Murphy, T. K., Pasternack, M., Thienemann, M., Williams, K., Walter, J., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0084 · Cited by 359
Munroe, M. E., Lu, R., Zhao, Y. D., Fife, D. A., Robertson, J. M., Guthridge, J. M., Niewold, T. B., Tsokos, G. C., Keith, M. P., Harley, J. B., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208140 · Cited by 256
Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen
Mahler, M., Fritzler, M. J., & Satoh, M. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.11.007 · Cited by 40
Self-citationMercury, Autoimmunity, and Environmental Factors on Cheyenne River Sioux Tribal Lands
Ong, J., Erdei, E., Rubin, R. L., Miller, C., Ducheneaux, C., O’Leary, M., Pacheco, B., Mahler, M., Henderson, P. N., Pollard, K. M., et al. (2014) · Autoimmune Diseases · doi:10.1155/2014/325461 · Cited by 25
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
Negrotto, L., Tur, C., Tintoré, M., Arrambide, G., Sastre-Garriga, J., Río, J., Comabella, M., Nos, C., Galán, I., Vidal-Jordana, A., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515575338 · Cited by 11
Metadata
- Authors
- Satoh, M., Chan, E. K. L., Ho, L. A., Rose, K. M., Parks, C. G., Cohn, R. D., Jusko, T. A., Walker, N. J., Germolec, D. R., Whitt, I. Z., Crockett, P. W., Pauley, B. A., Chan, J. Y. F., Ross, S. J., Birnbaum, L. S., Zeldin, D. C., & Miller, F. W.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2012-06-26
- Volume
- 64
- Issue
- 7
- Pages
- 2319-2327
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1985031981
- Cited by
- 448
- References
- 44
- FWCI
- 17.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.